• Dissecting Drug Responses: Innovations in In Vitro Cancer Ev

  2026-05-22

  Schwartz’s dissertation redefines how drug responses are assessed in cancer research by distinguishing between growth inhibition and cell death using refined in vitro assays. The study's insights support more precise interpretation of anticancer compound efficacy and suggest improved workflow design for translational research.

• BicD and MAP7 Synergize to Activate Drosophila Kinesin-1

  2026-05-21

  The referenced study uncovers how BicD and MAP7 act through complementary mechanisms to overcome the auto-inhibited state of Drosophila kinesin-1. By rigorously dissecting motor-adaptor interactions, the work advances our understanding of bidirectional transport regulation and offers new frameworks for studying adaptor protein-mediated motor activation.

• Cisplatin (CDDP): Apoptosis, Oxidative Stress, and PD-L1 Cro

  2026-05-21

  Explore the advanced mechanisms of Cisplatin (CDDP) in cancer research, including its interplay with apoptosis, oxidative stress, and immune checkpoint regulation. This article uniquely connects DNA damage with ER stress and PD-L1 stabilization, offering novel insights for tumor biology and assay design.

• Q-VD-OPh Pan-Caspase Inhibitor: Optimizing Apoptosis Researc

  2026-05-20

  Q-VD-OPh, a potent pan-caspase inhibitor from APExBIO, enables precise, reproducible apoptosis research and enhances cell viability post-cryopreservation. This guide details experimental workflows, protocol parameters, and troubleshooting strategies for maximizing assay performance across both in vitro and in vivo models.

• Cyclo (-RGDfC): Next-Gen Tumor Targeting for Translational I

  2026-05-20

  This thought-leadership piece unpacks how Cyclo (-RGDfC), a high-affinity cyclic RGD peptide, is redefining integrin αvβ3 targeting strategies for cancer and angiogenesis research. By blending mechanistic insights with protocol guidance, it offers translational researchers a roadmap for exploiting integrin-mediated pathways in tumor targeting, drug delivery, and in vitro modeling. The article synthesizes evidence from canine osteosarcoma studies, competitive peptide landscapes, and peer instrumentations, while situating Cyclo (-RGDfC) as a uniquely stable, reproducible tool for advanced workflows.

• Hematoxylin and Eosin Staining Kit: Technical Guide & Protoc

  2026-05-19

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) addresses reproducibility and workflow bottlenecks in visualizing tissue and cellular morphology for research applications. This kit streamlines histopathological and cytological staining of paraffin-embedded and frozen sections with ready-to-use solutions, but is not intended for clinical diagnostics or medical decision-making.

• Cytoskeleton-Dependent Autophagy Triggered by Mechanical Str

  2026-05-19

  This study demonstrates that mechanical stress-induced autophagy in human cell lines is critically dependent on the cytoskeleton, particularly on microfilaments, with microtubules playing a secondary role. These findings clarify the mechanotransduction process underlying stress-induced autophagy and inform strategies for targeted cell proliferation inhibition and apoptosis assays.

• Metformin HCl in Bone and Metabolic Research: Pathways, Prec

  2026-05-18

  Explore the multifaceted role of Metformin Hydrochloride in glucose metabolism and heterotopic ossification research. This article uniquely bridges molecular insight, advanced protocol guidance, and practical assay considerations for scientists advancing metabolic and bone biology.

• Sulfo-NHS-LC-Biotin: Technical Guide for Protein Biotinylati

  2026-05-18

  Sulfo-NHS-LC-Biotin addresses the need for selective, stable biotin labeling of cell surface and accessible proteins in aqueous environments, where membrane impermeability and irreversible conjugation are critical. It is not appropriate for reversible, intracellular, or non-protein biotinylation workflows.

• PTGER4 Signaling Modulates Class IIa HDACs and SPINK4 in Rec

  2026-05-17

  Anbazhagan et al. elucidate how PTGER4 signaling, triggered by mesenchymal stromal cell-derived PGE2, regulates class IIa HDAC phosphorylation and SPINK4 mRNA levels in human rectal epithelial cells. This mechanistic insight refines our understanding of epithelial homeostasis and inflammation, with implications for mucosal repair and disease.

• Estradiol-ERα Axis Modulates T Cell Recovery Post-Hemorrhagi

  2026-05-16

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by suppressing endoplasmic reticulum stress (ERS) via ERα and GPR30, but not ERβ. The findings clarify estrogen receptor subtype roles in immune regulation post-trauma and have implications for translational research on ER signaling in immune and cancer contexts.

• Cyclosporin A: Optimizing Immunosuppression and Mitochondria

  2026-05-15

  Cyclosporin A is a gold-standard tool for dissecting immunosuppressive pathways and mitochondrial function in both in vitro and in vivo models. This guide translates recent bench research and best practices into actionable workflows, troubleshooting tips, and advanced use-cases that leverage APExBIO's rigorously validated Cyclosporin.

• Oral Dextran Microgels for Targeted Cisplatin Delivery in Co

  2026-05-15

  This study introduces a dual-targeted, orally administered dextran microgel system encapsulating cisplatin and SPION-loaded lipid nanoparticles for localized colon cancer therapy. The approach overcomes gastrointestinal delivery barriers, enhances site-specific uptake, and demonstrates significant tumor inhibition, offering new directions for oral nanomedicine in oncology.

• NSD1-PPARγ-PTEN Axis Suppresses Glycolysis in Endometrial Ca

  2026-05-14

  This study reveals a novel epigenetic-metabolic pathway in endometrial cancer, where NSD1-mediated methylation of PPARγ enhances PTEN expression and suppresses tumor glycolysis. These findings highlight a targetable vulnerability in NSD1-deficient tumors and have practical implications for transcriptomic research workflows.

• Grazoprevir Hydrate: Precision Workflows for HCV Replication

  2026-05-14

  Harness Grazoprevir hydrate (MK-5172 hydrate) for high-fidelity, picomolar-level inhibition of hepatitis C virus replication. This guide details optimized experimental protocols, troubleshooting strategies, and the translational impact of this direct-acting antiviral in diverse HCV research and clinical contexts.

16714 records 2/1115 page Previous Next 12345 下5页 Last page